Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6284142 | 0.89 | HDAC1 (0.50) | SMN1; SMN2MAPK1HDAC8HDAC3HDAC4 | |
| SCHEMBL7038483 | 0.87 | HDAC1 (0.49) | L3MBTL1SMN1; SMN2MAPK1HDAC8HDAC3 | |
| SCHEMBL6291018 | 0.86 | CTSC (0.48) | L3MBTL1SMN1; SMN2MAPK1HDAC8HDAC3 | |
| SCHEMBL6287685 | 0.85 | HDAC1 (0.52) | L3MBTL1SMN1; SMN2MAPK1HDAC8HDAC3 | |
| SCHEMBL6287783 | 0.85 | HDAC8 (0.61) | SMN1; SMN2MAPK1HDAC8HDAC3HDAC4 | |
| SCHEMBL6288076 | 0.85 | HDAC1 (0.50) | L3MBTL1SMN1; SMN2MAPK1HDAC8HDAC3 | |
| SCHEMBL6287655 | 0.84 | HDAC1 (0.50) | SMN1; SMN2MAPK1HDAC8HDAC3HDAC4 | |
| Hydrochloric Acid SCHEMBL6286774 | 0.83 | HDAC1 (0.49) | L3MBTL1SMN1; SMN2MAPK1HDAC8HDAC3 | |
| SCHEMBL7037694 | 0.83 | HDAC1 (0.51) | HDAC8HDAC3HDAC4HDAC1HDAC7 | |
| Hydrochloric Acid SCHEMBL6290968 | 0.83 | HDAC1 (0.49) | L3MBTL1SMN1; SMN2MAPK1HDAC8HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030162724-A1 | Compounds exhibiting thrombopoietin-like activities | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162724-A1 | Compounds exhibiting thrombopoietin-like activities | MPL, THPO, TEK | L3MBTL1 1806/4885SMN1; SMN2 1648/4885MAPK1 338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.